GlaxoSmithKline | Lucro Operacional

Preço das Ações
2,226.00
Mudança Diária
-42.00 -1.85%
Mensal
23.98%
Anual
53.84%
Q1 Previsão
2,121.92




Lucro Operacional Alterar Data
AbbVie USD 5.81B 1.23B 2025-12
Alcon AG USD 332M 85M 2025-09
Almirall EUR 43.02M 28.78M 2025-06
Amgen USD 3.96B 464M 2025-12
argenx SE USD 349.97M 146.13M 2025-09
AstraZeneca USD 2.97B 4.48B 2025-12
Bayer EUR -543M 556M 2025-09
Biogen USD 659.6M 192.2M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Fresenius EUR 574M 14M 2025-09
Fresenius Medical Care EUR 449.94M 18.94M 2025-09
Galapagos EUR -41.67M 15.36M 2025-09
Genmab DKK 360M 172M 2025-06
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Glaxosmithkline GBP 3.76B 1.32B 2025-09
GRIFOLS EUR 352.11M 2.57M 2025-09
Hikma Pharmaceutical USD 187M 95M 2025-06
Lonza CHF 430M 104M 2024-12
Merck EUR 1.21B 180M 2025-09
Merck USD 6.24B 318M 2025-12
Novartis USD 4.5B 363M 2025-09
Novo Nordisk DKK 32.38B 1.7B 2025-12
Orion EUR 328.2M 207.2M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Philips EUR 719M 390M 2025-12
Recordati EUR 165.64M 15.69M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Smith & Nephew USD 440M 50M 2025-12
UCB EUR 1B 678M 2024-12


GlaxoSmithKline Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.